Skip to main content

Policy and Legislation

By Jeff Lagasse | 03:38 pm | March 07, 2023
The groups maintained that additional cuts to Medicaid would only cause further difficulties on the heels of the COVID-19 pandemic.
By Jeff Lagasse | 02:47 pm | March 06, 2023
Lower COVID-19 costs and better results in the individual market contributed to insurers' strong performance.
By Susan Morse | 10:36 am | March 06, 2023
A representative from the DEA was invited to attend the special listening session.
By Jeff Lagasse | 10:00 am | March 06, 2023
The reduction in private insurance premiums, BCBSA found, would increase federal tax revenues by about $29 billion.
By HIMSS TV | 06:00 am | March 06, 2023
<p>Ellison Institute director of policy, Gabriel Seidman, talks about the institute's work in creating a country-wide enterprise architecture for healthcare data that encompasses clinical, social determinants and public health data.</p> <p> </p>
By Jeff Lagasse | 10:48 am | March 03, 2023
The top drug agency proposed tighter limits for online prescriptions of some medications, such as Adderall and opioids.
By Jeff Lagasse | 03:48 pm | March 02, 2023
The House Oversight Committee said PBMs are distorting the pharmaceutical market and limiting high-quality care.
By HIMSS TV | 06:00 am | February 28, 2023
<p><span style="font-size:11pt"><span style="background:white"><span style="line-height:15.75pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Saudi Ministry of Health advisor for digital transformation Dr. Ahmed Balkhair explains how value-based healthcare helps improve the output of care and quality. </span></span></span></span></span></p>
By Jeff Lagasse | 11:29 am | February 27, 2023
The legislation mandates that HHS, MedPAC and MACPAC each conduct a report and issue recommendations on telehealth.
By Susan Morse | 11:32 am | February 23, 2023
CMS says it must examine whether a medication is reasonable and necessary while the FDA assesses whether medications are safe and effective.